GR76992B - - Google Patents

Info

Publication number
GR76992B
GR76992B GR69416A GR820169416A GR76992B GR 76992 B GR76992 B GR 76992B GR 69416 A GR69416 A GR 69416A GR 820169416 A GR820169416 A GR 820169416A GR 76992 B GR76992 B GR 76992B
Authority
GR
Greece
Application number
GR69416A
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27261323&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR76992(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of GR76992B publication Critical patent/GR76992B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR69416A 1981-10-03 1982-10-01 GR76992B (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8129937 1981-10-03
GB8208988 1982-03-26
GB08224871A GB2108510B (en) 1981-10-03 1982-09-01 Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Publications (1)

Publication Number Publication Date
GR76992B true GR76992B (el) 1984-09-04

Family

ID=27261323

Family Applications (1)

Application Number Title Priority Date Filing Date
GR69416A GR76992B (el) 1981-10-03 1982-10-01

Country Status (19)

Country Link
US (1) US5089400A (el)
EP (1) EP0076489B1 (el)
JP (2) JPH06104066B2 (el)
KR (1) KR920007665B1 (el)
AU (1) AU561104B2 (el)
DD (1) DD204266A5 (el)
DE (1) DE3280174D1 (el)
DK (1) DK170714B1 (el)
ES (2) ES516154A0 (el)
FI (1) FI80719C (el)
GB (1) GB2108510B (el)
GR (1) GR76992B (el)
HU (1) HU197047B (el)
IE (1) IE54051B1 (el)
IL (1) IL66920A0 (el)
NO (1) NO166494C (el)
NZ (1) NZ202058A (el)
PH (2) PH21524A (el)
PT (1) PT75643B (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
DE3220116A1 (de) 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
CA1271717A (en) * 1982-10-11 1990-07-17 National Biological Standards Board Polypeptides useful in vaccination against enteroviruses
CA1252046A (en) * 1982-11-04 1989-04-04 Martin J. Cline Methods for oncogenic detection
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
DE3685044D1 (de) * 1985-02-01 1992-06-04 Ici Plc Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
DE3686981T2 (de) * 1985-04-30 1993-07-08 Takeda Chemical Industries Ltd Produktion eines proteins.
ATE78262T1 (de) * 1985-06-11 1992-08-15 Ciba Geigy Ag Hybrid-interferone.
EP0242329B1 (en) 1986-04-15 1995-07-19 Ciba-Geigy Ag Monoclonal antibodies against interferon-induced human protein in pure form, and test kits containing these antibodies
TW218846B (el) * 1992-04-07 1994-01-11 Ciba Geigy
WO1994003624A1 (en) * 1992-08-04 1994-02-17 Auerbach Jeffrey I Methods for the isothermal amplification of nucleic acid molecules
US6261808B1 (en) 1992-08-04 2001-07-17 Replicon, Inc. Amplification of nucleic acid molecules via circular replicons
US5733733A (en) * 1992-08-04 1998-03-31 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
US5834202A (en) 1992-08-04 1998-11-10 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
US20020102236A1 (en) * 1994-12-08 2002-08-01 Taylor Peter William Liposomal interferon hybrid compositions
ATE207538T1 (de) 1995-02-09 2001-11-15 Behringwerke Ag Verfahren zur produktion von proteinen
US6087102A (en) * 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6685933B1 (en) 1998-07-28 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Services Interferon α hybrids
DE19919149A1 (de) * 1999-04-27 2000-11-16 Wieser Raimund J Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere
EP1355939A2 (en) * 2000-11-03 2003-10-29 Pestka Biomedical Laboratories, Inc. Interferons, uses and compositions related thereto
US20030065148A1 (en) * 2001-05-02 2003-04-03 Villarete Lorelie H. Method for expression of human interferon alpha 1 in Pichia pastoris
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
CA2591235C (en) * 2004-12-20 2014-03-11 Cadila Healthcare Limited Process for preparing high levels of interferon beta
WO2018092904A1 (ja) 2016-11-21 2018-05-24 日東電工株式会社 粘着シート
SG10201900706YA (en) 2016-11-21 2019-02-27 Nitto Denko Corp Pressure-sensitive adhesive sheet

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA796175B (en) * 1978-11-24 1980-11-26 Hoffmann La Roche Purified proteins and process therefor
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
IE54096B1 (en) * 1980-01-08 1989-06-21 Biogen Nv Dn sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
DK170476B1 (da) * 1980-04-03 1995-09-11 Biogen Inc Rekombinant DNA-molekyle, uni-cellulær vært transformeret med mindst ét rekombinant DNA-molekyle, fremgangsmåde til transformering af en uni-cellulær vært, samt fremgangsmåder til fremstilling af et polpeptid, der udviser den immunologiske eller biologiske aktivitet af human beta-interferon
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
ES8302778A1 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Also Published As

Publication number Publication date
FI823356L (fi) 1983-04-04
JPH07173195A (ja) 1995-07-11
PT75643A (en) 1982-11-01
NO823314L (no) 1983-04-05
DK170714B1 (da) 1995-12-18
HU197047B (en) 1989-02-28
PH21524A (en) 1987-11-16
US5089400A (en) 1992-02-18
ES8504936A1 (es) 1985-04-16
NZ202058A (en) 1986-05-09
EP0076489A2 (de) 1983-04-13
IE54051B1 (en) 1989-05-24
IE822385L (en) 1983-04-30
IL66920A0 (en) 1982-12-31
NO166494C (no) 1991-08-07
PH23119A (en) 1989-05-05
GB2108510B (en) 1984-12-12
PT75643B (en) 1986-11-13
JPS5890596A (ja) 1983-05-30
JP2612149B2 (ja) 1997-05-21
AU8895882A (en) 1983-04-14
DD204266A5 (de) 1983-11-23
FI823356A0 (fi) 1982-10-01
ES8601237A1 (es) 1985-11-01
JPH06104066B2 (ja) 1994-12-21
FI80719C (fi) 1990-07-10
EP0076489B1 (de) 1990-05-16
KR920007665B1 (ko) 1992-09-14
ES528141A0 (es) 1985-11-01
GB2108510A (en) 1983-05-18
KR840002031A (ko) 1984-06-11
NO166494B (no) 1991-04-22
EP0076489A3 (en) 1984-03-28
DK437382A (da) 1983-04-04
FI80719B (fi) 1990-03-30
ES516154A0 (es) 1985-04-16
AU561104B2 (en) 1987-04-30
DE3280174D1 (de) 1990-06-21

Similar Documents

Publication Publication Date Title
FR2503323B1 (el)
FR2498084B1 (el)
FR2498450B1 (el)
CH655529B (el)
FR2489954B1 (el)
FR2503651B3 (el)
FR2500445B1 (el)
FR2501850B3 (el)
FR2499331B1 (el)
DK45782A (el)
DE3136311C2 (el)
FR2498802B1 (el)
FR2501493B3 (el)
FR2500143B1 (el)
FR2504287B1 (el)
FR2497466B3 (el)
FR2502570B1 (el)
FR2498269B1 (el)
FR2504167B1 (el)
FR2498266B3 (el)
CH655541B (el)
FR2500897B1 (el)
FR2503524B1 (el)
FR2503286B2 (el)
FR2498418B3 (el)